ConductScience.org, home

Paper30722017

Population Pharmacokinetics of Intravenous Colistin in Pediatric Patients: Implications for the Selection of Dosage Regimens.

Ooi MH and 5 others. Clin Infect Dis, 2019. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Population Pharmacokinetics of Intravenous Colistin in Pediatric Patients: Implications for the Selection of Dosage Regimens. Papers, record 30722017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30722017

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Population Pharmacokinetics of Intravenous Colistin in Pediatric Patients: Implications for the Selection of Dosage Regimens.
PubMed
Journal
Clin Infect Dis
PubMed
Year
2019
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
1.62
iCite
Revised in PubMed
2020-09-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ooi MHMong How
2Ngu SJSing Jiat
3Chor YKYek Kee
4Li JJian
5Landersdorfer CBCornelia B
6Nation RLRoger L

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
ColistinMajor topic
Administration, Intravenous
Child
Child, Preschool
Female
Humans
Infant
Male

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42490869Pharmacokinetics of polymyxin drugs in special populations.Front Pharmacol2026https://conductscience.org/library/papers/42490869PubMed
40547403Development of an LC-MS/MS method for quantification of colistin and colistin methanesulfonate in human plasma and its application to stability studies and therapeutic drug monitoring.J Mass Spectrom Adv Clin Lab2025https://conductscience.org/library/papers/40547403PubMed
39452220Comparative Properties of Helical and Linear Amphipathicity of Peptides Composed of Arginine, Tryptophan, and Valine.Antibiotics (Basel)2024https://conductscience.org/library/papers/39452220PubMed
38223435Appropriate use of colistin in neonates, infants and children: Interim guidance.S Afr J Infect Dis2023https://conductscience.org/library/papers/38223435PubMed
37861791Personalized application of antimicrobial drugs in pediatric patients with augmented renal clearance: a review of literature.Eur J Pediatr2024https://conductscience.org/library/papers/37861791PubMed
37564179Individualized antibiotic dosage regimens for patients with augmented renal clearance.Front Pharmacol2023https://conductscience.org/library/papers/37564179PubMed
35947360Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic Modeling.Clin Pharmacokinet2022https://conductscience.org/library/papers/35947360PubMed
35694289Rational Framework for the Design of Trp- and Arg-Rich Peptide Antibiotics Against Multidrug-Resistant Bacteria.Front Microbiol2022https://conductscience.org/library/papers/35694289PubMed
35284983Population Pharmacokinetics of Moxifloxacin in Children.Paediatr Drugs2022https://conductscience.org/library/papers/35284983PubMed
34485491A retrospective review of colistin utilisation at a tertiary care academic hospital in South Africa.S Afr J Infect Dis2021https://conductscience.org/library/papers/34485491PubMed
33782000Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher Than Recommended Doses.Antimicrob Agents Chemother2021https://conductscience.org/library/papers/33782000PubMed
33771113Optimal empiric treatment for KPC-2-producing Klebsiella pneumoniae infections in critically ill patients with normal or decreased renal function using Monte Carlo simulation.BMC Infect Dis2021https://conductscience.org/library/papers/33771113PubMed
31956632A Randomized Clinical Trial Evaluating the Efficacy of Colistin Loading Dose in Critically Ill Children.J Res Pharm Pract2019https://conductscience.org/library/papers/31956632PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30722017

GET https://conductscience.org/api/papers/v1/30722017/authors